XJPX4997
Market cap353mUSD
Jan 20, Last price
712.00JPY
1D
0.57%
1Q
12.48%
Jan 2017
8.99%
Name
Nihon Nohyaku Co Ltd
Chart & Performance
Profile
Nihon Nohyaku Co., Ltd. researches, develops, and manufactures agrochemicals in Japan and internationally. The company offers fungicides, insecticides, and herbicides. It also provides chemical products for use in home gardening, greenery, and termite applications. In addition, it provides pharmaceuticals and animal health products, including topical anti-fungal agents, such as drugs for athlete's foot, as well as tick repellents for bees; and products for feed efficacy improvement; wood preservatives, and other agricultural materials; and landscape work, agrochemical residue analysis, and real estate rental services. Nihon Nohyaku Co., Ltd. was founded in 1926 and is headquartered in Tokyo, Japan. Nihon Nohyaku Co., Ltd. operates as a subsidiary of Adeka Corporation.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|
2023‑03 | 2022‑03 | 2021‑03 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | 2015‑09 | |
Income | ||||||||
Revenues | 102,090,000 24.64% | 81,910,000 14.52% | ||||||
Cost of revenue | 71,528,000 | 56,164,000 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | 30,562,000 | 25,746,000 | ||||||
NOPBT Margin | 29.94% | 31.43% | ||||||
Operating Taxes | 2,590,000 | 1,138,000 | ||||||
Tax Rate | 8.47% | 4.42% | ||||||
NOPAT | 27,972,000 | 24,608,000 | ||||||
Net income | 4,488,000 -0.31% | 4,502,000 3.64% | ||||||
Dividends | (1,220,000) | (1,181,000) | ||||||
Dividend yield | 2.31% | 2.46% | ||||||
Proceeds from repurchase of equity | (110,000) | |||||||
BB yield | 0.23% | |||||||
Debt | ||||||||
Debt current | 10,940,000 | 10,679,000 | ||||||
Long-term debt | 15,482,000 | 7,354,000 | ||||||
Deferred revenue | 1,012,000 | |||||||
Other long-term liabilities | 1,878,000 | 2,661,000 | ||||||
Net debt | 46,000 | 5,809,000 | ||||||
Cash flow | ||||||||
Cash from operating activities | (1,923,000) | (3,080,000) | ||||||
CAPEX | (1,718,000) | (1,641,000) | ||||||
Cash from investing activities | (1,338,000) | (706,000) | ||||||
Cash from financing activities | 6,171,000 | (2,558,000) | ||||||
FCF | 18,721,000 | 14,770,000 | ||||||
Balance | ||||||||
Cash | 15,644,000 | 12,224,000 | ||||||
Long term investments | 10,732,000 | |||||||
Excess cash | 21,271,500 | 8,128,500 | ||||||
Stockholders' equity | 59,271,000 | 55,464,000 | ||||||
Invested Capital | 80,404,500 | 78,566,500 | ||||||
ROIC | 35.19% | 35.68% | ||||||
ROCE | 29.88% | 29.66% | ||||||
EV | ||||||||
Common stock shares outstanding | 78,424 | 78,551 | ||||||
Price | 674.00 10.31% | 611.00 12.32% | ||||||
Market cap | 52,857,633 10.13% | 47,994,954 12.15% | ||||||
EV | 55,112,633 | 55,166,954 | ||||||
EBITDA | 32,470,000 | 27,495,000 | ||||||
EV/EBITDA | 1.70 | 2.01 | ||||||
Interest | 1,842,000 | 515,000 | ||||||
Interest/NOPBT | 6.03% | 2.00% |